metricas
covid
Annals of Hepatology Rifaximin treatment in patients with severe alcohol-associated hepatitis: A mult...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial
Do Seon Songa, Jin Mo Yanga, Young Kul Jungb,
Corresponding author
93cool@hanmail.net

Corresponding author.
, Hyung Joon Yimb, Hee Yeon Kimc, Chang Wook Kimc, Soon Sun Kimd, Jae Youn Cheongd, Hae Lim Leee, Sung Won Leee, Jeong-Ju Yoof, Sang Gyune Kimf, Young Seok Kimf
a Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Seoul, South Korea
b Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, South Korea
c Department of Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
d Department of Internal Medicine, Ajou University School of Medicine, Suwon, South Korea
e Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
f Department of Internal Medicine, Bucheon Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Bucheon, South Korea
Read
3450
Times
was read the article
885
Total PDF
2565
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 304 162 466
2025 11 330 217 547
2025 10 247 173 420
2025 9 194 104 298
2025 8 266 56 322
2025 7 300 38 338
2025 6 244 26 270
2025 5 214 6 220
2025 4 136 19 155
2025 3 107 21 128
2025 2 105 32 137
2025 1 79 13 92
2024 12 39 18 57
Show all

Follow this link to access the full text of the article

Article options
Tools
Supplemental materials